Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted quinuclidines as alpha 7-nicotinic acetylcholine receptor activity modulators

Substituted quinuclidines as alpha 7-nicotinic acetylcholine receptor activity modulators

US Patent 9657010 · Granted May 23, 2017

Estimated economic value: $8,109,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine recept2025
TREM2 stabilizing antibodies2022
Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine recep2022
Use of alpha 7 nicotinic acetylcholine receptor agonists2022
Use of nicotinic acetylcholine receptor alpha 7 activators2021
Heterocyclic derivatives and their use in the treatment of neurological disorder2020
Use of nicotinic acetylcholine receptor alpha 7 activators2020
Heterocyclic derivatives and their use in the treatment of neurological disorder2019
Heterocyclic derivatives and their use in the treatment of neurological disorder2018
Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists2017
Aza-bicycloalkyl ethers and their use as alpha7-nachr agonists2017
Substituted quinazolin-4-one derivatives2017